Fabry disease in the haemodialysis population: outcome of a UK screening study (SoFAH)
Despite the implementation of stringent screening criteria, we did not identify any new confirmed cases of Fabry disease in this large UK haemodialysis population.
Authors
- Tarekegn Geberhiwot (ORCID: https://orcid.org/0000-0002-3629-2338)
- Khai Ping Ng
- James O. Burton (ORCID: https://orcid.org/0000-0003-1176-7592)
- KM Shivakumar (ORCID: https://orcid.org/0000-0002-8062-9209)
- Lisa Crowley
- Dipanjan Banerjee (ORCID: https://orcid.org/0000-0003-3331-958X)
- Indranil Dasgupta (ORCID: https://orcid.org/0000-0002-1006-4281)
- Mansoor Hameed (ORCID: https://orcid.org/0000-0002-2341-7883)
- Johann Nicholas
- Madhu P. Menon (ORCID: https://orcid.org/0000-0002-4075-4961)
- Timothy Doulton (ORCID: https://orcid.org/0000-0002-1930-8190)
- Rizwan Hamer (ORCID: https://orcid.org/0000-0003-3750-3130)
- Satvik Ramakrishna (ORCID: https://orcid.org/0000-0002-5143-6010)
- Meenu Sandhu
Institutions
- University Hospitals Birmingham NHS Foundation Trust (GB)
- University of Leicester (GB)
- University Hospitals of North Midlands NHS Trust (GB)
- University Hospital Coventry (GB)
- Dudley Group NHS Foundation Trust (GB)
- University Hospitals Coventry and Warwickshire NHS Trust (GB)
- East Kent Hospitals University NHS Foundation Trust (GB)
- Shrewsbury and Telford Hospital NHS Trust (GB)
- University Hospitals of Derby and Burton NHS Foundation Trust (GB)
- The Royal Wolverhampton NHS Trust (GB)
- University of Birmingham (GB)
Publication Details
- Journal
- BMC Nephrology
- Published
- 2025-05-26
- DOI
- https://doi.org/10.1186/s12882-025-04127-x
- Citations
- 1
- Primary Topic
- Lysosomal Storage Disorders Research
- Type
- article
- Field-Weighted Citation Impact
- 1.16
Funders
- Sanofi